Join Growin Stock Community!

Heartbeam, inc.BEAT.US Overview

US StockHealthcare
(No presentation for BEAT)
My Watchlist

Ticker

Value

empty

There is no following symbol in this watchlist.

BEAT AI Insights

BEAT Overall Performance

BEAT AI Analysis & Strategy

AI Strategy

Browsing restrictions can be lifted for a fee.

BEAT Recent Performance

0.99%

Heartbeam, inc.

0.05%

Avg of Sector

-0.31%

S&P500

BEAT PowerScanner

Introduction >>

Power Squeeze

Surfing Trend

1 Day

1 Week

1 Month

BEAT Key Information

BEAT Financial Forecast

chart

Browsing restrictions can be lifted for a fee.

QuarterlyEPS ForecastQoQMaxMin
2026Q1
2026Q2
2026Q3
2026Q4
2027Q1

BEAT Profile

HeartBeam, Inc., a medical technology company, primarily focuses on telemedicine solutions for the detection and monitoring of cardiac disease outside a healthcare facility setting. The company also focuses on providing diagnostic data to physicians with care management of patients with cardiovascular disease. Its telehealth product comprises a credit card sized electrocardiogram machine and a cloud-based diagnostic software system to address the rapidly growing field of remote patient monitoring. The company was incorporated in 2015 and is headquartered in Santa Clara, California.

Price of BEAT

BEAT FAQ

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
-0.60
PE Ratio (TTM)
-
Forward PE
-
PS Ratio (TTM)
-
PB Ratio
153.16
Price-to-FCF
-
METRIC
VALUE
vs. INDUSTRY
Gross Margin
-%
Net Margin
-%
Revenue Growth (YoY)
-%
Profit Growth (YoY)
-%
3-Year Revenue Growth
-%
3-Year Profit Growth
-%
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
-0.60
PE Ratio (TTM)
-
Forward PE
-
PS Ratio (TTM)
-
PB Ratio
153.16
Price-to-FCF
-
Gross Margin
-%
Net Margin
-%
Revenue Growth (YoY)
-%
Profit Growth (YoY)
-%
3-Year Revenue Growth
-%
3-Year Profit Growth
-%

  • When is BEAT's latest earnings report released?

    The most recent financial report for Heartbeam, inc. (BEAT) covers the period of 2025Q3 and was published on 2025/09/30. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating BEAT's short-term business performance and financial health. For the latest updates on BEAT's earnings releases, visit this page regularly.

  • How much cash does BEAT have?

    At the end of the period, Heartbeam, inc. (BEAT) held Total Cash and Cash Equivalents of 1.86M, accounting for 0.65 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.

  • Is BEAT's EPS continuing to grow?

    According to the past four quarterly reports, Heartbeam, inc. (BEAT)'s earnings per share (EPS) shows a steady growth trend, with the latest EPS at -0.15. If EPS continues to rise due to revenue growth and cost optimization, it can support P/E valuation recovery and attract long-term investors.

  • What is the FCF of BEAT?

    Heartbeam, inc. (BEAT)'s Free Cash Flow (FCF) for the period is -3.24M, calculated as Operating Cash Flow minus Capital Expenditures, representing a rise of 4.9% compared with the previous period. Positive FCF growth provides stable funding for dividends, debt repayment, or strategic acquisitions, and is an important measure of true profitability and shareholder return potential.

BEAT Earnings Table

Unit : USD

QTRNon-GAAP EPSEPS YoYEPS Surprise %SalesSales YoYSales Surprise %NPM
Current
2025Q4
2025Q3
2025Q2
2025Q1